NCT05213702

A RCT to Evaluate the Efficacy and Safety of Automated Needle Targeting (ANT-X) System Compared to Traditional Free Hand Puncture for Renal Access in Percutaneous Nephrolithotomy (PCNL)

Name: Clinical Trial NCT05213702
Creator: University of Malaya
Keywords: Kidney Stone, Renal Calyx punture with traditional free hand or ANT-X device, device, clinical trial

A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Automated Needle Targeting (ANT-X) System Compared to Traditional Free Hand Puncture for Renal Access in Percutaneous Nephrolithotomy (PCNL) Performed by Urologists in Training.

University of Malaya·ClinicalTrials.gov·device·Device trialNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Kidney Stone
Drug/Device/Intervention: Renal Calyx punture with traditional free hand or ANT-X device
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: University of Malaya

Timeline & enrollment

Phase: N/A
Start date: Jan 25, 2022
End date: Dec 31, 2022
Enrollment: 60 participants

Primary outcome

Number of attempts required to obtain access,Time for the access

Summary

Objectives: This study aims to determine if the device provides an advantage over traditional free hand puncture by comparing the number of attempts required to obtain access, time to achieve access, radiation exposure to patient and surgeon; and complications.

ICD-10 classifications

Kidney dialysisSmall kidney, unspecifiedDisorder of kidney and ureter, unspecifiedInjury of kidneyUnspecified kidney failure

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05213702
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT05213702 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Malaya and is currently Not yet recruiting. The study focuses on Kidney Stone. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.